Allergen-induced release of GM-CSF and IL-8 in vitro by nasal polyp tissue from atopic subjects prolongs eosinophil survival

European Respiratory Journal

Volumn 10, Issue 7, 1997, Pages 1476-1482

  Park, H S ^a   Jung, K S ^b   Shute, J ^b   Roberts, K ^b   Holgate, S T ^b   Djukanovic R ^b  

^a Ajou University Medical Center   (South Korea)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cytokines; Eosinophils; Nasal polyps

Indexed keywords

ALLERGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 8; PHYTOHEMAGGLUTININ;

ARTICLE; ATOPY; CELL INFILTRATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHILIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NOSE POLYP; PRIORITY JOURNAL;

ALLERGENS; ANIMALS; CELL SURVIVAL; DUST; EOSINOPHILIA; EOSINOPHILS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INTERLEUKIN-8; MITES; NASAL POLYPS; TUMOR CELLS, CULTURED;

EID: 0030807006     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10071476     Document Type: Article

References (43)

1. Stoop AE, Vander Heijden HAMD, Biewenga J, Van der Bann S. Eosinophils in nasal polyps and nasal mucosa: An immuno-histochemical study. J Allergy Clin Immunol 1993; 91: 616-622 .
2. Jordana M, Dolovich J, Ohno I, Finotto S, Denburg J. Nasal polyposis: a model for chronic inflammation. In: Busse WW, Holgate ST, eds. Asthma and Rhinitis. Boston, US, Oxford, UK, Blackwell Scientific Publications, 1995; pp.156-166.
3. Hamann KJ. Eosinophil mediators. In: Busse WW, Holgate ST, eds. Asthma and Rhinitis. Boston, US, Oxford, UK, Blackwell Scientific Publications, 1995; pp. 298-327.
4. 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 1994; 93: 864-869.
5. Derunck R. The physiology of transforming factor-α. Adv Cancer Res 1992; 58: 27-52.
6. Bernard JA, Russette ML, Moses HL. The cell biology of transforming growth factor-α. Biochem Biophys Acta 1990; 1032: 79-87.
7. Wong DTW, Weller PF, Galli SJ, et al. Human eosinophils express transforming factor-α. J Exp Med 1990; 172: 673-681.
8. Kita H, Ohnishi T, Okubo Y, Weiler D, Abram JS, Gleich GJ. Granulocyte/macrophage colony stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med 1991; 174: 745-748.
9. Moqbel R, Hamid Q, Ying S, et al. Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony stimulating factor in activated human eosinophils. J Exp Med 1991; 174: 749-752.
10. Descreunaux P, Janin A, Colombel JF, et al. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med 1992; 175: 293-296.
11. Hamid Q, Barkans J, Meng Q, et al. Human eosinophil synthesize and secrete interleukin-6 in vitro. Blood 1992; 80: 1496-1501.
12. Ohno I, Lea R, Finotto S, et al. Granulocyte/macrophage colony stimulating factor gene expression by eosinophils in nasal polyposis. Am J Respir Cell Mol Biol 1991; 5: 505-510.
13. Braun RK, Franchini M, Erard F, et al. Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore. Eur J Immunol 1993; 23: 956-960.
14. Ying S, Barata-Taborda L, Meng Q, Humbert M, Kay AB. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 (MCP-3) and RANTES in the skin of human atopic subjects: relationship to eosinophil, T-cell and macrophage recruitment. J Exp Med 1995; 181: 2153-2159.
15. Costa JJ, Matossian K, Resnick MB, et al. Human eosinophils can express the cytokines tumour necrosis factor-α and macrophage inflammatory protein-1α. J Clin Invest 1993; 91: 2673-2684.
16. Slavin RG. Allergy is not a significant cause of nasal polyps. Arch Otolaryngol Head Neck Surg 1992; 118: 343.
17. Caplin I, Haynes TJ, Spahn J. Are nasal polyps an allergic phenomenon? Ann Allergy 1971; 29: 631-634.
18. Liu C-M, Shun C-T, Hsu M-M. Lymphocyte subsets and antigen-specific IgE antibody in nasal polyps. Ann Allergy 1994; 72: 19-24.
19. Osborn L, Hession C, Tizard R, et al. Direct expression and cloning of vascular cell adhesion molecule-1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989; 59: 1203-1211.
20. Schleimer RP, Sterbinsky SA, Kaiser J, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 1992; 148: 1086-1092.
21. Tai PC, Sun L, Spry CJF. Effects of IL-5, granulocyte/macrophage colony stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin Exp Immunol 1991; 85: 312-316.
22. Rothenberg ME, Owen WF, Siberstein DS, et al. Human eosinophils have prolonged survival, enhanced functional properties and become hypodense when exposed to human interleukin 3. J Clin Invest 1988; 81: 1986-1992.
23. Ohtoshi T, Vancheri C, Cox G, et al. Monocyte-macrophage differentiation induced by human upper airway epithelial cells. Am J Respir Cell Moll Biol 1991; 4: 255-263.
24. Vancheri C, Ohtoshi T, Cox G, et al. Neutrophilic differentiation induced by human upper airway fibroblast-derived granulocyte-macrophage colony-stimulating factor (GM-CSF). Am J Respir Cell Mol Biol 1991; 4: 1117.
25. Bradding P, Roberts JA, Britten KM, et al. Interleukin-4, -5, and tumor necrosis factor-α in normal and asthmatic airway: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10: 471-480.
26. Howell CJ, Pujol JL, Crea AE, et al. Identification of an alveolar macrophage derived activity in bronchial asthma that enhances leukotriene C4 generation by human eosinophils stimulated by ionophore A23187 as a granulocyte-macrophage colony-stimulating factor. Am Rev Repir Dis 1989; 140: 1340-1347.
27. Corrigan CJ, Kay AB. The lymphocyte in asthma. In: Busse WW, Holgate ST, eds. Asthma and Rhinitis. Blackwell Scientific Publications, Boston, US, Oxford, UK, 1995; 450-464.
28. Ebisawa M, Liu MC, Yamada T, et al. Eosinophil transendothelial migration induced by cytokines. II Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines. J Immunol 1994; 152: 4590-4596.
29. Shute JK. Interleukin-8 is a potent eosinophil chemoattractant. Clin Exp Allergy 1994; 24: 203-206.
30. Shute JK, Lindley I, Peichl P, Holgate ST, Church MK, Djukanovic R. Mucosal IgA is an important moderator of eosinoph́il responses to tissue-derived chemoattractants. Int Arch Allergy Immunol 1995; 107: 340-341.
31. Tai C-P, Spry CJ, Peterson C, Venge P, Olsson I. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 1984; 309: 182-184.
32. Owen Jr. WF, Rothenberg ME, Silberstein DS, et al. Regulation of human eosinophil viability, density and function by granulocyte/macrophage colony stimulating factor in the presence of 3T3 fibroblasts. J Exp Med 1987; 166: 129-141.
33. Hansel TT, De Vries IJM, Iff T, et al. An improved immunomagnetic procedure for isolation of eosinophils. J Immunol Method 1991; 145: 1-6.
34. Mullol J, Xaubet A, Gaya A, et al. Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps. Clin Exp Allergy 1995; 25: 607-615.
35. Xaubet A, Mullol J, Lopez E, et al. Comparison of the role of nasal polyp and normal nasal mucosal epithelial cells on in vitro eosinophil survival. Mediation by GM-CSF and inhibition by dexamethasone. Clin Exp Allergy 1994: 24: 307-317.
36. Xing Z, Ohtoshi T, Ralph P, Gauldie J, Jordana M. Human upper airway structural cell-derived cytokines support human peripheral blood monocyte survival: a potential mechanism for monocyte-macrophage accumulation in the tissue. Am J Respir Cell Mol Biol 1992; 6: 212-218.
37. Furukawa M, Yomashita T, Kumazawa T, Stouchi K, Saito K. Evidence of platelet-activating factor in nasal polyps. ORL J Otorhinolaryngol Relat Spec 1992; 54: 29-32.
38. Kaliner M, Wasserman SI, Austen FK. Immunologic release of chemical mediators from human nasal polyps. N Engl J Med 1973; 289: 277-281.
39. Mullol J, Xaubet A, López E, Roca-Ferrer J, Picado C. Comparative study of the effects of different glucocorticosteroids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps. Thorax 1995; 50: 270-274.
40. Strieter RM, Standiford TJ, Rolfe MW, Kunkel SL. Interleukin-8. In: Kelley J, ed. Cytokines of the Lung. Lung Biology in Health and Disease. New York, Basel, Hong Kong, Marcel Dekker, 1993; pp. 281-306.
41. Walker C, Bauer W, Braun RK, et al. Activated T-cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994; 150: 1038-1048.
42. Webb LMC, Ehrengruber MU, Clark-Lewis I, Baggiolini M, Rot A. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci USA 1993; 90: 7158-7162.
43. Warringa RA, Mengelers HJJ, Raaijmakers JAM, Bruijnzeel PLB, Koenderman L. Upregulation of formyl-peptide and interleukin-induced eosinophil chemotaxis in patients with allergic asthma. J Allergy Clin Immunol 1993; 91: 1198-1205.